Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 6, 2001, Pages 1660-1670

  De Backer, Marianne D ^a,c   Ilyina, Tatiana ^a   Ma, Xiao Jun ^c,d   Vandoninck, Sandy ^a   Luyten, Walter H M L ^a   Bossche, Hugo Vanden ^b  

^a JANSSEN RESEARCH FOUNDATION   (Belgium)

^b R W Johnson Pharmaceutical Res I ^*  (Belgium)

^c JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^d Arcturus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DNA MICROARRAY; DRUG INDUSTRY; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DNA-BINDING PROTEINS; ETHER-A-GO-GO POTASSIUM CHANNELS; GENE EXPRESSION REGULATION, FUNGAL; GENOME, FUNGAL; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANS-ACTIVATORS;

EID: 0035012570     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.6.1660-1670.2001     Document Type: Article

References (37)

1. Bammert, G. F., and J. M. Fostel. 2000. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob. Agents Chemother. 44:1255-1263.
2. Brown, P. O., and D. Botstein. 1999. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21:33-7.
3. Daum, G., N. D. Lees, M. Bard, and R. Dickson. 1998. Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae. Yeast 14:1471-1510.
4. Dimster-Denk, D., J. Rine, J. Philips, S. Scherer, P. Cundiff, K. DeBord, D. Gilliland, S. Hickman, A. Jarvis, L. Tong, and M. Ashby. 1999. Comprehensive evaluation of isoprenoid biosynthesis regulation in Saccharomyces cerevisiae utilising the Genome Reporter Matrix. J. Lipid Res. 40:850-860.
5. Dixon, G., D. Scanlon, S. Cooper, and P. Broad. 1997. A reporter gene assay for fungal sterol biosynthesis inhibitors. J. Steroid Biochem. Mol. Biol. 62: 2-3, 165-167.
6. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Holstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863-14868.
7. Fonzi, W. A., and M. V. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.
8. Harousseau, J. L., A. W. Dekker, A. Stamatoullas-Bastard, A. Fassas, W. Linkesch, J. Gouveia, R. De Bock, M. Rovira, W. F. Seifert, H. Joosen, M. Peeters, and K. De Beule. 2000. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B. Antimicrob. Agents Chemother. 44:1887-1893.
9. Henry, K. W., J. T. Nickels, and T. D. Edlind. 2000. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob. Agents Chemother. 44:2693-2700.
10. Kelly, S. L., M. A. Quail, J. Rowe, and D. E. Kelly. 1992. Sterol 14α-demethylase: target of the azole antifungal agents, p. 155-187. In P. B. Fernandes (ed.), New approaches for antifungal drugs. Birkhauser, Boston, Mass.
11. Kontoyiannis, D. P., N. Sagar, and K. D. Hirschi. 1999. Overexpression of Ergl 1p by the regulatable GAL1 promoter confers fluconazole resistance in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 43:2798-2800.
12. 22-desaturase from the pathogenic fungus Candida glabrata. Antimicrob. Agents Chemother. 43:1725-1728.
13. Launhardt, H., A. Hinnen, and T. Munder. 1998. Drug-induced phenotypes provide a tool for the functional analysis of yeast genes. Yeast 14:435-942.
14. Marbois, B. N., and C. F. Clarke. 1996. The COQ7 gene encodes a protein in Saccharomyces cerevisiae necessary for ubiquinone biosynthesis. J. Biol. Chem. 271:2995-3004.
15. Mariceau, C., J. Joets, D. Pousset, M. Guilloton, and F. Karst. 1996. FEN2: a gene implicated in the catabolite repression-mediated regulation of ergosterol biosynthesis in yeast. Yeast 12:531-539.
16. Marichal, P. 1999. Mechanisms of resistance to azoic antifungal compounds. Curr. Opin. Anti-infective Investig. Drugs 1:318-333.
17. Marichal, P., J. Gorrens, L. Laurijssens, K. Vermuyten, C. Van Hove, L. Le Jeune, P. Verhasselt, D. Sanglard, M. Borgers, F. V. S. Ramaekers, F. Odds, and H. Vanden Bossche. 1999. Accumulation of 3-ketosteroids induced by itraconazole in azole resistant clinical Candida albicans isolates. Antimicrob. Agents Chemother. 43:2663-2670.
18. Matthews, R. C., B. Maresca, J. P. Burnie, A. Cardona, L. Carrulu, S. Conti, G. S. Deepe, A. M. Florez, S. Franceschelli, E. Garcia, L. S. Gargano, G. S. Kobayashi, J. G. McEwen, B. L. Ortiz, A. M. Oviedo, L. Polonelli, J. Ponton, and A. Restrepo. 1998. Stress proteins in fungal diseases. Med. Mycol. 36(Suppl. 1):45-51.
19. M'baya, B., M. Fegueur, M. Servouse, and F. Karst. 1989. Regulation of squalene synthase and squalene epoxidase activities in Saccharomyces cerevisiae. Lipids 24:1020-1023.
20. Odds, F. C. 1996. Antifungal therapy, p. 35-48. In C. C. Kibbler, D. W. R. Mackenzie, and F. C. Odds (ed.), Principles and practice of clinical mycology. John Wiley & Sons, Chichester, United Kingdom.
21. Parks, L. W. 1978. Metabolism of sterols in yeast. Crit. Rev. Microbiol. 6:301-341.
22. Rosamond, J., and A. Allsop. 2000. Harnessing the power of the genome in the search for new antibiotics. Science 287:1973-1976.
23. Sanglard, D., F. Ischer, M. Monod, and J. Bille. 1996. Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrobiol. Agents Chemother. 40:2300-2305.
24. Smith, S. J., J. H. Crowley, and L. W. Parks. 1996. Transcriptional regulation by ergosterol in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 16:5427-5432.
25. 5-encoding gene which suppresses ketoconazole hypresensitivity in a NADPH-P450 reductase-deficient strain. Gene 149:123-127.
26. Turi, T. G., and J. C. Loper. 1992. Multiple regulatory elements control expression of the gene encoding S. cerevisiae cytochrome P450, Ianosterol 14 alpha-demethylase (ERG11). J. Biol. Chem. 267:2046-2056.
27. Vanden Bossche, H. 1985. Biochemical targets for antifungal azole derivatives hypothesis on the mode of action. Curr. Top. Med. Mycol. 1:313-351.
28. Vanden Bossche, H. 1990. Importance and role of sterols in fungal membranes, p. 135-157. In P. J. Kuhn, A. P. J. Trinci, M. J. Jung, M. W. Goosey, and L. G. Copping (ed.), Biochemistry of cell walls and membranes in fungi. Springer-Verlag, Berlin, Germany.
29. Vanden Bossche, H. 1995. Chemotherapy of human fungal infections, p. 431-484. In H. Lyr (ed.), Modern selective fungicides. Gustav Fischer Verlag, Jena, Germany.
30. Vanden Bossche, H., J. Heeres, L. J. J. Backx, P. Marichal, and G. Willemsens. 1993. Discovery, chemistry, mode of action, and selectivity of itraconazole, p. 263-283. In J. W. Rippon and R. A. Fromtling (ed.), Cutaneius antifungal agents. Marcel Dekker, Inc., New York, N.Y.
31. Vanden Bossche, H., and L. Koymans. 1998. Cytochromes P450 in fungi. Mycoses 41(Suppl. 1):32-38.
32. Vanden Bossche, H., G. Willemsens, and P. Marichal. 1987. Anti-Candida drugs: the biochemical basis for their activity. Crit. Rev. Microbiol. 15:57-72.
33. Vanden Bossche, H., G. Willemsens, W. Cools, P. Marichal, and W. Lauwers. 1983. Hypothesis on the molecular basis of the antifungal activation of N-substituted imidazoles and triazoles. Biochem. Soc. Trans. 11:665-667.
34. Vanden Bossche, H., P. Marichal, L. Le Jeune, M. C. Coene, J. Gorrens, and W. Cools. 1993. Effects of itraconazole on cytochrome P-450-dependent sterol 14-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrob. Agents Chemother. 37:2101-2105.
35. Vanden Bossche, H., F. Dromer, I. Improvisi, M. Lozano Chiu, J. H. Rex, and D. Sanglard. 1998. Antifungal drug resistance in pathogenic fungi. Med. Mycol. 36(Suppl. 1):119-128.
36. Wheat, J., P. Marichal, H. Vanden Bossche, A. Le Monte, and P. Connolly. 1997. Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum. Antimicrob. Agents Chemother. 41:410-414.
37. White, T. C. 1997. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases on azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 42:1488-1494.